Skip to main content
Equibles
SRTS logo

SRTS · Sensus Healthcare, Inc.

Track SRTS — free

Use SRTS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SRTS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$3.15 +0.03 (+0.96%) At close · Sep 11
Rebalance outlook locked
Market Cap
$51.86M
Shares
16.46M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$3.15 Open$3.13 Day$3.10–3.18 52W close$2.69–5.30 Avg vol 30d37K Short int216K · 1.3% float · 3.8d Short vol65% Last earningsAug 13, 2026 DataJan 2020–Sep 2026 Filing10-Q · Aug 14

Up next

Next earnings call
Nov 16, 2026 Est · unconfirmed · in 9 wks
Latest filing: 10-Q
filed Aug 14, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$17.51M
Trailing 12 months
Net income (TTM)
−$15.48M
Trailing 12 months
Revenue growth YoY
-68.7%
Year over year
Operating margin
-75.7%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
-13.4%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$15.19M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+0.9%
Year over year · more shares
Price change (1Y)
-2.8%
Trailing year
Short interest
1.3%
Latest settlement · 3.8 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Sell Momentum Very Weak Sentiment Neutral Fundamentals Fair Quant / Vol Very High
Market backdrop VIX 15.8 · calm Equity put/call 0.58
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −16%
below
Price vs 50-day avg +2%
above
RSI (14) 48
neutral
MACD trend Negative
52-week position 18%
mid-range
Momentum
relative strength
Very Weak
1-month return 0%
trailing
6-month return −19%
trailing
YTD return −21%
this year
Relative strength −36%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $3 › 200d $4 — 200d above 50d
Institutional flow Distributing
-9% holders QoQ · +4 funds added
Insider flow Accumulating
Net +$563.5K over 90 days · 0% sells
Short interest Rising
1.31% of float · ▲ +3.3% MoM · 3.8 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
40 holders — near 3-yr low, contrarian setup
Squeeze score 57
elevated · 0–100
Fundamentals
Fair
Revenue growth −34%
Y/Y
Gross margin 43%
contracting
EPS growth −215%
Y/Y
Free cash flow $332.0K
Quant / Vol
risk profile
Very High
Volatility 65%
annualized · 1-yr
Max drawdown −49%
past year
ATR 6.0%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Sell
2 · 3 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−16% Bearish
Price vs 50-day avg
+2% Bullish
RSI (14)
48 Neutral
MACD trend
Negative Bearish
52-week position
18% Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross) No cross
50d $3 › 200d $4 — 200d above 50d
Institutional flow Distributing
-9% holders QoQ · +4 funds added
Insider flow Accumulating
Net +$563.5K over 90 days · 0% sells
Short interest Rising
1.31% of float · ▲ +3.3% MoM · 3.8 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
40 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
Range low $3 Now $3 · 18% Range high $5
vs 200-day avg -16% vs 50-day avg +2%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.

Versus peers

Medical Devices — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
SRTS
Sensus Healthcare, Inc.
this stock
$51.86M -20.9% -34.3% — 1.3%
ABT
Abbott Laboratories
 $177.58B -18.6% +5.7% 28.6 1.3%
MDT
Medtronic plc
 $116.35B -5.3% +8.4% 22.4 0.9%
SYK
Stryker Corp
 $105.70B -21.6% +11.2% 28.6 2.0%
BSX
Boston Scientific Corp
 $62.29B -54.9% +12.5% 17.4 3.3%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
40
% held
22.7%
Net QoQ
-271.9K sh
Top holder
Pacific Ridge Capital Par…
Held Float
View
Held by Funds
Fund positions
30
View
Short & Settlement
Short Interest Rising
Shares short
216.2K
Days to cover
3.8d
Change
+7.0K sh
View
Short Volume
Short vol %
65%
As of
Sep 11, 2026
Short Total
View
Fails to Deliver
FTD shares
724
Value
$2.2K
As of
Aug 10, 2026
View
Off-Exchange
Off-exchange %
45.0%
Week of
Aug 3, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net buying
Net (90d)
+$563.5K
Buyers / Sellers
2 / 0
Buyers Sellers
View
Financials
Financials
Revenue (FY)
$27.5M
Net income (FY)
$-7.7M
EPS diluted
$-0.47
View
Filings
SEC Filings
Latest
10-Q
Filed
Aug 14, 2026
This year
12
View
Earnings & Events
Earnings Calls
Last call
Aug 13, 2026
View

Performance

5D 20D 120D MTD YTD
SRTS -3.4% -0.3% -18.6% -11.0% -20.9%
SPY -1.2% -1.8% +17.8% -0.4% +12.1%
vs SPY -2.2% +1.4% -36.4% -10.7% -32.9%
Key facts CIK 1494891 CUSIP 81728J109 13F (30d) 11 filings 11 filers Visit website